1-6 of 6
Yoshitaka Narita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Analysis Data from Multi-Center Retrospective Observational Study of Effectiveness, Safety, and Treatment Status of Tirabrutinib in 161 Japanese Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma: Rosetta Study

Motoo Nagane, Manabu Natsumeda, Fumiharu Ohka, Fumiyuki Yamasaki, Hajime Yonezawa, Nobuyoshi Sasaki, Shigeru Yamaguchi, Kensuke Tateishi, Yoshitaka Narita, Yasukazu Kawai, Hiroyuki Sugahara, Jyunichiro Kuroda, Takeshi Okuda, Tomoo Matsutani, Manabu Kinoshita, Naoto Tomita, Keiichiro Hattori, Jun Muto, Noriaki Kitamura, Keita Kinoshita, Kazuhiko Mishima
Journal: Blood
Blood (2024) 144 (Supplement 1): 572.
https://doi.org/10.1182/blood-2024-198558
Published: 2024
Journal Articles

Post-Hoc Analysis of the Final, Three-Year Follow-up Results of a Phase I/II Study on Tirabrutinib (ONO-4059) in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Noriko Fukuhara, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Hajime Yonezawa, Katsunori Asai, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa
Journal: Blood
Blood (2023) 142 (Supplement 1): 4472.
https://doi.org/10.1182/blood-2023-180438
Published: 2023
Journal Articles

Association between Microenvironment-Related Genes and Prognosis of Primary Central Nervous System Lymphoma

Keiichiro Hattori, Kenichi Makishima, Naoki Kurita, Yoshiaki Abe, Mamiko Sakata-Yanagimoto, Tatsuhiro Sakamoto, Sakurako Suma, Yasuhito Suehara, Ryota Matsuoka, Daisuke Matsubara, Motoo Nagane, Ryota Ishii, Ryo Nishikawa, Shota Tanaka, Akitake Mukasa, Yoshitaka Narita, Koichi Ichimura, Shingo Takano, Eiichi Ishikawa, Shigeru Chiba
Journal: Blood
Blood (2023) 142 (Supplement 1): 6081.
https://doi.org/10.1182/blood-2023-181517
Published: 2023
Journal Articles

Quality of Life and Karnofsky Performance Status in Patients with Relapse or Refractory Primary Central Nervous System Lymphoma during Phase I/II Study of Tirabrutinib

Yasuhito Terui, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yoshiki Arakawa, Hajime Yonezawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa
Journal: Blood
Blood (2021) 138 (Supplement 1): 4561.
https://doi.org/10.1182/blood-2021-146439
Published: 2021
Journal Articles

Phase 1/2 Study of Tirabrutinib (ONO/GS-4059), a Next-Generation Bruton's Tyrosine Kinase (BTK) Inhibitor, Monotherapy in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

Motoo Nagane, MD PhD, Yoshitaka Narita, MD PhD, Kazuhiko Mishima, MD PhD, Yasuhito Terui, MD PhD, Yoshiki Arakawa, MD PhD, Hajime Yonezawa, MD PhD, Katsunori Asai, MD PhD, Noriko Fukuhara, MD PhD, Kazuhiko Sugiyama, MD PhD, Naoki Shinojima, MD PhD, Junsaku Kitagawa, Arata Aoi, Ryo Nishikawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1586.
https://doi.org/10.1182/blood-2019-123362
Published: 2019
Journal Articles

Comparison of Genetic Profiling of Primary Central Nervous System (CNS) Lymphoma before and after Extra-CNS Relapse

Kosuke Toyoda, MD, Junko Nomoto, MD PhD, Yasuji Miyakita, MD, Yoshitaka Narita, MD PhD, Akiko Miyagi Maeshima, MD PhD, Nobuhiko Yamauchi, MD, Suguru Fukuhara, MD, Wataru Munakata, MD PhD, Dai Maruyama, MD PhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5135.
https://doi.org/10.1182/blood.V130.Suppl_1.5135.5135
Published: 2017